Quarterly report pursuant to Section 13 or 15(d)

Marketable securities (Details Narrative)

v3.3.0.814
Marketable securities (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 10 Months Ended 12 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Oct. 31, 2014
Dec. 31, 2014
Jan. 31, 2014
Sale of shares $ (584) $ (584)      
MusclePharm [Member]              
Shares receivable             1,200,000
Common stock shares owned             600,000
Price per share         $ 10.00    
Sale of shares         $ 5,400,000    
Shares released         90,000    
Recognized loss on return of shares           $ 584,000  
Musclepharm repurchase of shares         $ 250,000    
Portion of shares in escrow         260,000